Medical Xpress September 4, 2024
The cost of whole-genome sequencing is approaching that of the traditional genetic tests currently used for patients diagnosed with acute leukemia, according to a new study published in the Journal of Medical Economics.
With costs falling and whole-genome sequencing adding new information that can improve treatment decisions, researchers see a future in which whole-genome sequencing becomes the standard for acute leukemias.
Whole-genome sequencing is becoming increasingly common in health care to improve the diagnosis and thus treatment of cancer. While today’s standard diagnostic tests for acute leukemias use a range of different genetic tests, research has shown that whole-genome sequencing as a single method can potentially replace current tests.
In addition, it can provide new and important information in a...
Today's Sponsors
Today's Sponsor